MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

World MS Day

Connect on World MS Day – May 30th, 2020

MStranslate
May 28, 2020
Community
World MS Day will take place in two days time on Saturday 30th May, 2020.  The campaign for the next three years (2020-2022) is called "MS Connections", which "is all about building community connection,...
epstein-barr virus

Epstein-Barr Virus & MS: New Study Outcomes

MStranslate
May 20, 2020
Epstein-Barr virus, Infection, Research, Videos
1 Comment
Research Summary: Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis A German study involving 901 people living with early multiple sclerosis (MS) has found...
mental health

Strategies for Managing Mental Health: Dr Sally Shaw

MStranslate
May 14, 2020
Community, Dr Sally Shaw, Mental Health, Q&A, Symptoms
2 Comments
On April 29, 2020, we premiered a video on our Facebook page discussing strategies for managing mental health during the coronavirus (COVID-19) pandemic. For this discussion, we were joined by Australian...
Ursolic acid

Fruit Peel Compound Shows Treatment Potential

MStranslate
April 7, 2020
Research, Treatments
Research Summary:  A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination A newly published study in the highly respected medical journal,...
COVID-19

Facebook Live: COVID-19 & Multiple Sclerosis

MStranslate
March 23, 2020
Q&A, Videos
On March 20, 2020, we conducted a very important Facebook Live broadcast, discussing what is known about coronavirus (COVID-19) and its implications for people living with multiple sclerosis. The opportunity...
sleep conditions

Sleep Conditions and Their Impact on Multiple Sclerosis

MStranslate
March 11, 2020
Fatigue, Lifestyle, Quality of Life, Symptoms
1 Comment
We hate to state the obvious but... A while ago a study was published that showed that one of the main causes of fatigue in people living with multiple sclerosis was difficulty sleeping. Upon sharing these...
remyelination

Facebook Live: Remyelination – March 2020

MStranslate
March 11, 2020
Q&A, Remyelination, Videos
1 Comment
On March 5, 2020, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss one of the most important topics in multiple sclerosis research,...
friendship

The Importance of Friendship for People Living With MS

MStranslate
March 3, 2020
Community, Quality of Life, Symptoms
“Friendship is born at that moment when one person says to another: ‘What! You too? I thought I was the only one.” - C.S Lewis Two of the most common feelings that we hear from people living...
mesenchymal stem cell

Mesenchymal Stem Cell Trial for Multiple Sclerosis

MStranslate
February 2, 2020
Conferences, Dr Travis Stiles, ECTRIMS, Stem Cells, Treatments
EXCLUSIVE INTERVIEW At ECTRIMS Congress 2019, we had the privilege of interviewing Prof. Dimitrios Karussis (Neurologist, Hadassah Hospital) about the exciting results from his mesenchymal stem cell trial...
AHSCT

BEAT-MS Trial to Compare AHSCT to MS Treatments

MStranslate
January 14, 2020
Research, Stem Cells, Treatments
Over recent years, we have seen a large expansion in the number of available treatments for people living with relapsing-remitting multiple sclerosis (RRMS).  As well as this, we have recently seen a number...
  1. 5
  2. 6
  3. 7
  4. 8
  5. 9
  6. 10
  7. 11

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.